AAPlasma’s Oxystrike Highlighted in the 2020 Congressional Report

AAPlasma’s Oxystrike Platform was highlighted in the Department of Defense’s 2020 Industrial Capabilities Congressional Report

AAPlasma is excited to see that our DLA Project “Pulsed Plasma Treatment for Rapid In-Between-Patient Disinfection of Non-Invasive Ventilation Systems and Personal Protection Equipment After COVID-19 Use” was highlighted in the 2020 Industrial Capabilities Report to Congress. Out of the 4367 companies to receive SBIR funding in 2020, only two, AAPlasma and e-Spin Technologies, were highlighted in this report for our willingness and ability to pivot our research to help our nation respond to COVID-19.

AAPlasma’s project, Oxystrike, was originally developed to disinfect fresh fruits and vegetables for the Defense Logistics Agency. When COVID-19 rocked the nation in 2020, we were asked to pivot this research to disinfect PPE (N95 respirators, or simply face masks). With the help of our friends at the Nextfab Product Development Team, Drexel University, Xenex Disinfection Services, and a long list of >40 individuals and companies, AAPlasma was able to meet this challenge. AAPlasma is honored to be recognized in this report and is proud to be a part of the effort to foster a “robust, resilient, and innovative industrial base.”

Check back to see updates on this project as well as our other projects!